The nurse is caring for a one-month-old infant admitted for suspected congenital hypothyroidism. Which diagnostic test results should the nurse report to the healthcare provider?

Choice A reason: Arrested growth is a common outcome of renal osteodystrophy in children. It is caused by the impaired bone formation and mineralization that result from the abnormal calcium, phosphorus, vitamin D, and parathyroid hormone levels in chronic kidney disease. Arrested growth can lead to short stature, delayed puberty, and poor quality of life.

Choice B reason: Weight gain is not a specific outcome of renal osteodystrophy in children. It may be related to other factors, such as fluid retention, decreased physical activity, or increased appetite due to medications or hormonal imbalances. Weight gain can worsen the kidney function and increase the risk of cardiovascular complications.

Choice C reason: Low blood pressure is not a specific outcome of renal osteodystrophy in children. It may be caused by other factors, such as dehydration, blood loss, infection, or medications. Low blood pressure can affect the perfusion of vital organs and cause dizziness, fainting, or shock.

Choice D reason: Hypervitaminosis D is not a specific outcome of renal osteodystrophy in children. It may occur as a side effect of vitamin D supplementation, which is often prescribed to treat or prevent renal osteodystrophy. Hypervitaminosis D can cause hypercalcemia, which can lead to nausea, vomiting, constipation, confusion, or kidney stones.

Choice A reason: Recommending that the parent bring the child in for immediate evaluation is not the best response by the nurse. This may cause unnecessary anxiety and expense for the parent and the child. Albuterol is a bronchodilator that relaxes the muscles in the airways and increases air flow to the lungs. It is used to treat or prevent bronchospasm, or narrowing of the airways, in people with asthma or chronic obstructive pulmonary disease (COPD). It is also used to prevent exercise-induced bronchospasm. It is a quick-relief medication that can be used as needed when the child has difficulty breathing.

Choice B reason: Advising the parent that over-use of the medication may cause chronic bronchitis is not the best response by the nurse. This is not true and may discourage the parent from giving the medication to the child when needed. Chronic bronchitis is a type of COPD that causes inflammation and mucus production in the airways. It is usually caused by smoking or exposure to air pollution, not by albuterol. Albuterol does not cause chronic bronchitis, but it can help relieve the symptoms of bronchospasm in people who have it.

Choice C reason: Confirming that the medication helps to reduce airway inflammation is not the best response by the nurse. This is not accurate and may confuse the parent. Albuterol does not reduce airway inflammation, but it relaxes the muscles around the airways so that they open up and the child can breathe more easily. Albuterol is not an anti-inflammatory medication, but a bronchodilator. Anti-inflammatory medications, such as corticosteroids, are used to prevent or reduce inflammation in the airways, but they are not quick-relief medications like albuterol.

Choice D reason: Assuring the parent that they are using the medication correctly is the best response by the nurse. This shows that the nurse understands the purpose and the proper use of albuterol and that the nurse supports the parent's decision to give the medication to the child when needed. The nurse should also educate the parent on how to use the inhaler device correctly, how to monitor the child's symptoms and peak flow, and when to seek medical attention if the child's condition worsens.